EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Prenatal hemoglobinopathy screening & prevention in India: A cross-sectional study

Rajat Kumar Agarwal, Rakesh Dhanya, Lalith Parmar, Amit Sedai, George Mani, Aniruddha Dhar, Santhosh Hegde, Sundar Periyavan, Nagaraj Erappa, Anusha S, Sudha Kumar, Balasubramani Rengaraj und 6 weitere

The Indian Journal of Medical Research · 30.06.2025 · 161 · 441-448

DOI: 10.25259/ijmr_1003_2024 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift The Indian Journal of Medical Research, online erschienen am 30.06.2025. Verfasst von Rajat Kumar Agarwal und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, Sankalp India Foundation, Bengaluru, Karnataka, India. Hauptthemen laut MEDLINE: Prenatal Diagnosis, Hemoglobinopathies, Anemia, Sickle Cell, beta-Thalassemia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives India carries a significant burden of hemoglobinopathies, with beta-thalassemia and sickle cell disease (SCD) carrier rates ranging from 3-40 per cent by region. Despite the importance of universal screening, widespread prevention is challenging due to socio-cultural stigma, low awareness, and poor follow up. Sankalp’s thalassemia prevention program used targeted prenatal screening rather than mass or cascade screening. The aim of this study was to assess the efficacy and feasibility of a targeted antenatal screening strategy for the prevention and management of severe hemoglobinopathies in India.

Methods

A cross-sectional study was conducted in 36 districts across five Indian States between April 2023 and March 2024. Pregnant women within 20 wk gestation attending public hospitals were screened for hemoglobinopathies using high-performance liquid chromatography (HPLC). If a woman was identified as a carrier, her partner was tested. At-risk couples received molecular confirmation, followed by prenatal testing and counselling to support informed decisions.

Results

Of the total 34,647 enrolled women, 33,270 (96%) were screened, identifying 2,268 (6.8%) carriers, 903 (2.7%) beta thalassemia, 1,176 (3.5%) SCD, and 189 (0.6%) other hemoglobinopathies. Partners of 1,959 women (86.4%) were tested, identifying 339 at-risk couples. Testing was unnecessary in five cases due to benign mutations. Fetal testing was completed in 246 pregnancies, identifying 65 affected foetuses. Among these, 44 families (68%) chose to discontinue pregnancy. One affected birth was prevented for every 787 families enrolled. Interpretations & Conclusions The Sankalp program for hemoglobinopathies prevention demonstrates that targeted antenatal screening within public healthcare is a feasible, effective, and scalable strategy for hemoglobinopathy prevention in socio-economically disadvantaged populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prenatal DiagnosisHemoglobinopathiesAnemia, Sickle Cellbeta-ThalassemiaHumansFemaleIndiaPregnancyAdultCross-Sectional Studies

Stichwörter der Autor:innen

Antenatal screeninghemoglobinopathypreventionsickle cell diseasethalassemia

Autor:innen und Institutionen

  • Department of Clinical Research, Sankalp India Foundation, Bengaluru, Karnataka, India.
  • Thalassemia Prevention, Sankalp India Foundation, Bengaluru, Karnataka, India.
  • Jagriti InnoHealth Platforms Pvt Ltd, Bengaluru, Karnataka, India.
  • Adi Advanced Centre for Fetal Care, Bengaluru, Karnataka, India.

Zitieren

APA

Agarwal, R. K., Dhanya, R., Parmar, L., Sedai, A., Mani, G., Dhar, A., Hegde, S., Periyavan, S., Erappa, N., S, A., Kumar, S., Rengaraj, B., G N, M., N, M., Prasad, R. N., Fernandes, R., Makkam, A., & Faulkner, L. (2025). Prenatal hemoglobinopathy screening & prevention in India: A cross-sectional study. The Indian Journal of Medical Research, 161, 441-448. https://doi.org/10.25259/ijmr_1003_2024

Vancouver

Agarwal RK, Dhanya R, Parmar L, Sedai A, Mani G, Dhar A, et al. Prenatal hemoglobinopathy screening & prevention in India: A cross-sectional study. The Indian Journal of Medical Research. 2025;161:441-448. doi:10.25259/ijmr_1003_2024

BibTeX
@article{Agarwal2025,
  author = {Agarwal, Rajat Kumar and Dhanya, Rakesh and Parmar, Lalith and Sedai, Amit and Mani, George and Dhar, Aniruddha and Hegde, Santhosh and Periyavan, Sundar and Erappa, Nagaraj and S, Anusha and Kumar, Sudha and Rengaraj, Balasubramani and G N, Mamatha and N, Manjunatha and Prasad, R N and Fernandes, Rashmi and Makkam, Adinarayan and Faulkner, Lawrence},
  title = {Prenatal hemoglobinopathy screening & prevention in India: A cross-sectional study},
  journal = {The Indian Journal of Medical Research},
  year = {2025},
  volume = {161},
  pages = {441--448},
  doi = {10.25259/ijmr_1003_2024}
}
Kostenlos starten →